| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/25/2000 | US6093693 B cell activation |
| 07/25/2000 | US6093571 Efficient process by selectively irradiating shell of the pollen with ion beams without affecting the cell nucleus and thereafter immersing the irradiated pollen in a solution containing the specific gene or dna of interest |
| 07/25/2000 | US6093570 Cotransfecting cells permissive for adenovirus-associated virus replication with a recombinant adeno-associated virus vector, a helper adeno-associated virus vector and a helper virus vector to produce infectious virions and collecting |
| 07/25/2000 | US6093569 Introducing into regenerable plant cells a recombinant dna of a promoter of specific nucleotide sequence linked to a heterologous dna of interest, and identifying or selecting transformed cells; for high constitutive expression |
| 07/25/2000 | US6093568 Dna construct of a dna sequence encoding a coconut plant 1-acylglycerol-3-phosphate acyltransferase peptide joined to a second dna sequence heterologous to first; study of plant fatty acid synthesis systems; development of oil sources |
| 07/25/2000 | US6093567 Gene therapy for cystic fibrosis |
| 07/25/2000 | US6093565 Nucleotide sequence; hybridization probes; antisense agents; for diagnosis and treatment of immunological disorders (immunosuppresants, autoimmune disorders) and nervous system disorders (alzheimer's disease); anticarcinogenic agents |
| 07/25/2000 | US6093563 Chondroitin lyase enzymes |
| 07/25/2000 | US6093562 Alpha-amylase enzyme variants of increased thermostability or decreased isoelectric point, having specified substitutions or deletions to the parent alpha-amylase amino acid sequence; improved washing/textile desizing performance |
| 07/25/2000 | US6093561 Human lysophospholipase |
| 07/25/2000 | US6093557 Electrospraying apparatus and method for introducing material into cells |
| 07/25/2000 | US6093555 Amido and peptido modified enzymatic nucleic acid molecules |
| 07/25/2000 | US6093554 Inducible production of proteins, peptides or rnas; dna derived from rna virus dependent upon viral rna/rna polymerase(rp), the derived sequence codes for cis elements for replication, but not viral rna/rp or viral coat protein |
| 07/25/2000 | US6093553 Immortalized brain endothelial cells |
| 07/25/2000 | US6093549 Identifying candidate therapeutic agents which interfere with huntingtin associated protein-1(hap1) and huntingtin binding by contacting these proteins and a compound, determining if the compound diminishes the two proteins from binding |
| 07/25/2000 | US6093545 Contacting the sample with nucleic acid probe or primer and detecting hybridization to the target nucleic acid; diagnosis of nervous system disorders including eating and sleep disorders, irritable bowel and glandular disorders |
| 07/25/2000 | US6093544 Rupestris stem pitting associated virus nucleic acids, proteins, and their uses |
| 07/25/2000 | US6093540 Method for diagnosing a disorder characterized by expression of a BAGE tumor rejection antigen precursor |
| 07/25/2000 | US6093539 Encodes a water-soluble polypeptide of portion of human cd4 glycoprotein able to complex with human immunodeficiency virus envelope glycoprotein; viricides; vaccines |
| 07/25/2000 | US6093538 Nucleotide sequences of 10 to 100 nucleotides in length for rapid detection of urogenital bacteria linked to disorders |
| 07/25/2000 | US6093537 Detecting target sequence in sample by mixing with pair of nucleotide sequences, hybridizing, attaching nucleotide sequences together, adding nucleotide sequence specific binding proteins, and detecting binding |
| 07/25/2000 | US6093535 By analyzing genomic dna present in a sample of varicella virus and determining if dna satisfies eight characteristics |
| 07/25/2000 | US6093395 Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production |
| 07/25/2000 | US6093393 Methods for preparing and using clonogenic fibroblasts and transfected clonogenic fibroblasts |
| 07/25/2000 | US6093392 Comprising a recombinant adeno-associated viral vector |
| 07/25/2000 | US6092764 Interface seal for an aircraft |
| 07/25/2000 | CA2286314A1 Human tumor suppressor gene |
| 07/25/2000 | CA2160131C New bacillus thuringiensis strains and their insecticidal proteins |
| 07/25/2000 | CA2109727C Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 07/25/2000 | CA2094611C Hiv immunotherapeutics |
| 07/25/2000 | CA2091450C Plant parasitic nematode control |
| 07/25/2000 | CA2042831C A recombinant promoter for gene expression in monocotyledonous plants |
| 07/25/2000 | CA2040595C Gene coded for a polypeptide which enhances virus infection of host insects |
| 07/25/2000 | CA2015077C A yeast cell of the genus schwanniomyces |
| 07/25/2000 | CA2010256C Protein anti-cancer agent |
| 07/20/2000 | WO2000042561A2 Oligonucleotide mediated nucleic acid recombination |
| 07/20/2000 | WO2000042560A2 Methods for making character strings, polynucleotides and polypeptides |
| 07/20/2000 | WO2000042559A1 Methods of populating data structures for use in evolutionary simulations |
| 07/20/2000 | WO2000042432A1 Purification process using magnetic particles |
| 07/20/2000 | WO2000042221A2 Method for the affinity isolation of newly synthesized rna |
| 07/20/2000 | WO2000042220A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 07/20/2000 | WO2000042219A1 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| 07/20/2000 | WO2000042217A2 Method for electrochemically detecting nucleic acid-oligomer hybridisation events |
| 07/20/2000 | WO2000042216A2 Genetic predisposition to abnormal calcification conditions |
| 07/20/2000 | WO2000042215A1 Method and polynucleotides for determining translational efficiency of a codon |
| 07/20/2000 | WO2000042211A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith |
| 07/20/2000 | WO2000042208A1 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 07/20/2000 | WO2000042207A2 Soybean transformation method |
| 07/20/2000 | WO2000042206A1 An expression silencing system and different uses thereof |
| 07/20/2000 | WO2000042205A2 Herbicide target gene and methods |
| 07/20/2000 | WO2000042204A2 Trans-acting factors in yeast |
| 07/20/2000 | WO2000042203A2 Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells |
| 07/20/2000 | WO2000042202A1 A method for introducing substances into cells, and use of said method |
| 07/20/2000 | WO2000042201A2 Human peptidases |
| 07/20/2000 | WO2000042200A1 Strictosidine glucosidase from catharanthus roseus and its use in alkaloid production |
| 07/20/2000 | WO2000042199A1 Biologically active reverse transcriptases |
| 07/20/2000 | WO2000042198A1 An e. coli protein tyrosine kinase and its uses |
| 07/20/2000 | WO2000042197A1 Recombinant enzyme with excellent d-amino acid oxidase activity and production thereof |
| 07/20/2000 | WO2000042196A2 Human methionine synthase reductase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, cancer, and down's syndrome |
| 07/20/2000 | WO2000042195A2 Schizochytrium pks genes |
| 07/20/2000 | WO2000042194A2 Mutant hepatitis b surface antigen and testing |
| 07/20/2000 | WO2000042193A1 Neisseria meningitidis antigen |
| 07/20/2000 | WO2000042192A1 Neisseria meningitidis polypeptide basb052 |
| 07/20/2000 | WO2000042191A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 07/20/2000 | WO2000042190A1 Polynucleotide and method for selectively expressing a protein in a target cell or tissue of a plant |
| 07/20/2000 | WO2000042189A1 Interleukin-20 |
| 07/20/2000 | WO2000042188A2 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses |
| 07/20/2000 | WO2000042187A1 Interleukin-17 related mammalian cytokine (il-171). polynucleotides encoding them. uses |
| 07/20/2000 | WO2000042186A1 NOVEL INTERFERON-$g(a) |
| 07/20/2000 | WO2000042185A1 Methods for regulating the stability of recombinant proteins and products useful therein |
| 07/20/2000 | WO2000042184A1 Zlrr3: a human leucine-rich repeat protein |
| 07/20/2000 | WO2000042183A2 Tumor marker zsig62 |
| 07/20/2000 | WO2000042182A1 Mammalian cortexin-like proteins and polynucleotides encoding the same |
| 07/20/2000 | WO2000042181A1 Minor histocompatibility antigens and their use in diagnosis and treatment of tumors |
| 07/20/2000 | WO2000042180A1 Novel protein |
| 07/20/2000 | WO2000042179A2 Complex-forming proteins |
| 07/20/2000 | WO2000042178A2 Antagonist blockade of crf2 receptors for the treatment of psy chiatric disorders and the use of chimeric antisense oligonucleotides in in vivo cns studies of gene function |
| 07/20/2000 | WO2000042177A1 Method for isolating dna from biological materials |
| 07/20/2000 | WO2000042176A1 Selection of monoclonal antibodies |
| 07/20/2000 | WO2000042175A1 Methods for making proteins containing free cysteine residues |
| 07/20/2000 | WO2000042174A1 Double nuclear transfer method and results thereof |
| 07/20/2000 | WO2000042173A1 Catalytic molecules |
| 07/20/2000 | WO2000042172A2 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | WO2000042171A1 Compositions isolated from plant cells and their use in the modification of plant cell signaling |
| 07/20/2000 | WO2000042170A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/20/2000 | WO2000042167A1 Eukaryotic cell-based system for identifying gene modulators |
| 07/20/2000 | WO2000042165A2 Bone marrow-specific protein |
| 07/20/2000 | WO2000042072A2 Polypeptide variants with altered effector function |
| 07/20/2000 | WO2000042070A1 Mammalian alpha-helical protein - 12 |
| 07/20/2000 | WO2000042069A1 Bone stimulating factor |
| 07/20/2000 | WO2000042068A2 Hiv related peptides |
| 07/20/2000 | WO2000042064A1 Peptides for inhibiting hpv e6 proteins |
| 07/20/2000 | WO2000042063A2 Peptides for inhibiting hbv core proteins |
| 07/20/2000 | WO2000041807A1 New hydrophobic polymer comprising fluorine moieties |
| 07/20/2000 | WO2000041740A2 Particles for oral delivery of peptides and proteins |
| 07/20/2000 | WO2000041731A1 Reverse gene therapy |
| 07/20/2000 | WO2000041717A2 Chorionic gonadotropin dna vaccines and methods |
| 07/20/2000 | WO2000041610A2 Mitochondrial dna damage as a predictor of coronary atherosclerotic heart disease |
| 07/20/2000 | WO2000041566A1 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/20/2000 | WO2000041561A1 Bacterial cell component-unresponsive model mouse |